We have initiated coverage of BridgeBio Pharma, a biotechnology firm focused on discovering and delivering transformative medicine for genetic diseases. We assign the firm a no-moat rating due to the substantial risk of value destruction, as a significant portion of its valuation hinges on one pipeline candidate, acoramidis. The shares appear undervalued against our $36.70 fair value estimate.
The successful commercialization of acoramidis could establish BridgeBio as a key player in the ATTR-CM market, significantly improving its path to profitability.
BridgeBio has historically faced challenges in developing pipeline candidates and bringing them to market.
|
Metric
|
BBIO
|
ALNY
|
BNTX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 156.05 | 37.28 |
Price/Book Value | — | — | 1.37 |
Price/Sales | 20.04 | 14.77 | 9.83 |
Price/Cash Flow | — | 67.81 | 48.25 |
|
Metric
|
BBIO
|
ALNY
|
BNTX
|
|---|---|---|---|
Quick Ratio | 3.34 | 2.78 | 7.25 |
Current Ratio | 4.59 | 3.01 | 7.54 |
Interest Coverage | −4.52 | −0.35 | — |
|
Metric
|
BBIO
|
ALNY
|
BNTX
|
|---|---|---|---|
Return on Assets (Normalized) | −70.01% | 5.94% | −1.51% |
Return on Equity (Normalized) | — | — | −1.70% |
Return on Invested Capital (Normalized) | −75.25% | 21.50% | −4.02% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Fwwsntwszh | Flxg | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Cwjrnlkk | Ghllmk | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Krwbyhdc | Tcgjp | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Wgxppfdm | Tkbkdb | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Jqrbtghg | Hypg | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Bmsdgfsz | Dtgjt | $28.1 Bil | |||
| Moderna Inc
MRNA
| Kchzfknw | Xtsn | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Nyrgryfyd | Fwzhz | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Gbmcxqzb | Fyssrkc | $13.4 Bil | |||
| Incyte Corp
INCY
| Znkkbpcm | Pkgdfnq | $12.7 Bil |
:quality(80)/author-service-images-prod-us-east-1.publishing.aws.arc.pub/morningstar/ca9ef979-0207-4e37-b392-91618ebc1841.jpg)
United States